Oral PL-8177 Reduces Gut Inflammation in Rat Model of IBD, New Results Show

Oral PL-8177 Reduces Gut Inflammation in Rat Model of IBD, New Results Show
Palatin Technologies‘, investigational PL-8177, taken orally, reached the large intestine and colon, resulting in significantly reduced inflammation and damage in a bowel inflammation rat model. The poster on the study, titled “Probing the Role of the MC1 Receptor in Resolution With a Selective MC1 Receptor Agonist—PL-8177” was presented at the “The Resolution of Inflammation in

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *